Commonwealth Equity Services’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-10,684
| Closed | -$36K | – | 2885 |
|
|
2018
Q3 | $36K | Sell |
10,684
-250
| -2% | -$842 | ﹤0.01% | 2715 |
|
|
2018
Q2 | $41K | Hold |
10,934
| – | – | ﹤0.01% | 2676 |
|
|
2018
Q1 | $44K | Hold |
10,934
| – | – | ﹤0.01% | 2601 |
|
|
2017
Q4 | $51K | Hold |
10,934
| – | – | ﹤0.01% | 2570 |
|
|
2017
Q3 | $78K | Buy |
10,934
+250
| +2% | +$1.78K | ﹤0.01% | 2438 |
|
|
2017
Q2 | $77K | Hold |
10,684
| – | – | ﹤0.01% | 2396 |
|
|
2017
Q1 | $66K | Hold |
10,684
| – | – | ﹤0.01% | 2308 |
|
|
2016
Q4 | $63K | Hold |
10,684
| – | – | ﹤0.01% | 2229 |
|
|
2016
Q3 | $57K | Sell |
10,684
-2,674
| -20% | -$14.3K | ﹤0.01% | 2160 |
|
|
2016
Q2 | $88K | Hold |
13,358
| – | – | ﹤0.01% | 2123 |
|
|
2016
Q1 | $62K | Buy |
13,358
+3,074
| +30% | +$14.3K | ﹤0.01% | 2116 |
|
|
2015
Q4 | $52K | Sell |
10,284
-6,100
| -37% | -$30.8K | ﹤0.01% | 2099 |
|
|
2015
Q3 | $58K | Buy |
+16,384
| New | +$58K | ﹤0.01% | 2041 |
|